Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G for Avenue Therapeutics, Inc. Common Stock (ATXI).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2024.
Ikarian Capital, LLC - 31 Dec 2024 SCHEDULE 13G Report for Avenue Therapeutics, Inc. Common Stock (ATXI)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- ATXI
- Shares outstanding
- 2,058,824 shares
- Disclosed Ownership
- 140,000 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 13:25:08 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 6.8% ownership in Avenue Therapeutics, Inc. Common Stock (ATXI) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 13:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 6.8% | 140,000 | 0 | 140,000 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 6.8% | 140,000 | 0 | 140,000 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager |